APA

Wong M. C. S., Wang H. H. X., Kwan M. W. M., Zhang D. D. X., Liu K. Q. L., Chan S. W. M., Fan C. K. M., Fong B. C. Y., Li S. T. S. & Griffiths S. M. (20160331). Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review. : PloS one.

Chicago

Wong Martin C S, Wang Harry H X, Kwan Mandy W M, Zhang Daisy D X, Liu Kirin Q L, Chan Sky W M, Fan Carmen K M, Fong Brian C Y, Li Shannon T S and Griffiths Sian M. 20160331. Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review. : PloS one.

Harvard

Wong M. C. S., Wang H. H. X., Kwan M. W. M., Zhang D. D. X., Liu K. Q. L., Chan S. W. M., Fan C. K. M., Fong B. C. Y., Li S. T. S. and Griffiths S. M. (20160331). Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review. : PloS one.

MLA

Wong Martin C S, Wang Harry H X, Kwan Mandy W M, Zhang Daisy D X, Liu Kirin Q L, Chan Sky W M, Fan Carmen K M, Fong Brian C Y, Li Shannon T S and Griffiths Sian M. Comparative effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors and human glucagon-like peptide-1 (GLP-1) analogue as add-on therapies to sulphonylurea among diabetes patients in the Asia-Pacific region: a systematic review. : PloS one. 20160331.